What makes a good COVID-19 vaccine? Serum Institute's Adar Poonawalla explains
Defining the four attributes, Serum Institute of India CEO Adar Poonawalla posted that a good vaccine must be safe, should offer long-term protection against targeted disease, can be transported and stored at a manageable temperature, and lastly, affordable
- Nov 18, 2020,
- Updated Nov 18, 2020 12:16 PM IST
Serum Institute of India CEO Adar Poonawalla has defined what makes a "good vaccine". Taking to Twitter on Tuesday, November 18, Poonawalla said that a vaccine can be called a 'good vaccine' only if it meets four key criteria.
Pune-based pharma giant's CEO said that a good vaccine must be safe, should offer long-term protection against targeted disease, can be transported and stored at a manageable temperature, and lastly, affordable.
"Definition of a good vaccine = 1. Safe 2. Offers long-term protection against targetted disease 3. Can be transported and stored at a manageable temperature 4. Affordable to all of humanity," Poonawalla tweeted.
His tweet comes after drugmakers Moderna and Pfizer recently claimed that their respective coronavirus vaccine candidate showed 90 per cent efficacy.
Serum Institute of India CEO Adar Poonawalla has defined what makes a "good vaccine". Taking to Twitter on Tuesday, November 18, Poonawalla said that a vaccine can be called a 'good vaccine' only if it meets four key criteria.
Pune-based pharma giant's CEO said that a good vaccine must be safe, should offer long-term protection against targeted disease, can be transported and stored at a manageable temperature, and lastly, affordable.
"Definition of a good vaccine = 1. Safe 2. Offers long-term protection against targetted disease 3. Can be transported and stored at a manageable temperature 4. Affordable to all of humanity," Poonawalla tweeted.
His tweet comes after drugmakers Moderna and Pfizer recently claimed that their respective coronavirus vaccine candidate showed 90 per cent efficacy.